Navigation Links
Stem Cell Banking Evokes Mixed Response

Cord blood banking initiative by Sir Richard Branson has received a mixed and varied response in Britain. While this was welcomed by the doctors and scientific community,// others opined that it may not be as beneficial as it sounds.

The human blood extracted from placenta and umbilical cord is called cord blood. This can be collected before the placenta is delivered or after the newborn baby is separated from the umbilical cord. This blood is an excellent source of hematopoietic stem cells which can be further stored and used for transplantation needs.

Currently there are private and public cord blood banks. While the public banks are generally used for everyone, private ones are meant for the families of the donors.

According to Professor Robin Lovell-Badge of Medical Research Council National Institute for Medical Research, the use of these stem cells can only be limited to treat a set of disorders of the blood. But the embryonic stem cells may have more remedial measures in treating degenerative diseases.

Many of them seem to concur with the guarded approach of the Royal College of Obstetricians and Gynaecologists (RCOG) which felt that children from low-risk families cannot be treated with private cord blood.

Dr Jacky Boivin from Cardiff University feels that the family should be adequately informed about the storage of cold blood and they should not under any circumstances be forced to take emotional decisions.

But the midwives have a different perspective to the entire issue. They feel that their primary objective of delivering a baby should not be diverted as safety of the mother and the newborn is of utmost importance than drawing blood from the cord or placenta.
JYT
'"/>




Page: 1

Related medicine news :

1. A Novel System For Clinical Banking Of Umbilical Cord Blood
2. A Worm Turns: Banking on Blood From a Little Lugworm
3. Doctor Dissuades Mothers from Umbilical Cord Banking
4. Banking (T)issues : cloning issue surfaces
5. Umbilical Cord Blood Banking of Negligible Value: Experts
6. Choking Game, Rage Among US Teens, Evokes Deep Concern
7. Mixed Opinion Regarding Common Medical And Engineering Entrance Test
8. New Medicare Plan - Mixed Reaction among Pharmacists.
9. Mixed Orientation Marriages Calls for Deeper Understanding
10. Mixed response Evoked Among The Tribal Elders For The Call On Smoking Ban
11. Mixed Wards Cause Trauma in Female Patients in Britain
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: